some ppl can confuse share price, with market opportunity as being the same as someone is willing to pay. Also what they “want” to get for to perhaps retire.
Basically Pharma will pay 50%-100% premium to SP max otherwise they can just action a hostile takeover. Won’t vote then they won’t buy simple as that.
Prometheus is a good example $10b but peak sales estimate at $20b. As always Pharma defaults to the lower of a x5 multiple and 50%-100% SP premium.
Ann: Race continues Board renewal - appoints new Chair, page-74
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |